Cite
HARVARD Citation
Tipton, M. et al. (n.d.). 2456. Immunogenicity and Safety of a MenACWY-CRM Booster Dose 4–6 Years After Primary Quadrivalent Meningococcal Conjugate Vaccination in Healthy US Adolescents and Adults. Open forum infectious diseases. p. S735. [Online].